What is PCSK9? Our liver makes a protein called proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 regulates how many LDL receptors you have. Studies have shown that if you have naturally high PCSK9, you are more likely to have high cholesterol. PCSK9 inhibitors decrease LDLR degradation by PCSK9, and thereby improve LDL-C clearance and lower plasma LDL-C Here are some landmark trials on PCSK9 inhibitors: Landmark Trials on PCSK9 Inhibitors 1. *FOURIER Trial (2017)*: Evaluated the efficacy and safety of evolocumab (Repatha) in reducing cardiovascular events in patients with established cardiovascular disease. Results showed a 15% reduction in major cardiovascular events. 2. *ODYSSEY OUTCOMES Trial (2018)*: Assessed the efficacy and safety of alirocumab (Praluent) in reducing cardiovascular events in patients with acute coronary syndrome. Results showed a 15% reduction in major cardiovascular events. 3. *SPIRE-1 and SPIRE-2 Trials (2014)*: Evaluated the efficacy and safet...
Dr. Usman's Cardiology Notes
Cardiology Notes: Clinical Cases including ECG, Echocardiography, Cath, and MOCK Exams to sharpen your cardiology data interpretation skills. Healthcare is stressful!!! Learning cardiology shouldn't be !!!